| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.6M | +6.7% | -26.8% |
| Cost of Revenue | $3.3M | +1.7% | -11.7% |
| R&D Expense | $3.9M | -37.0% | +66.0% |
| SG&A Expense | $188.8M | +851.7% | +535.0% |
| Operating Income | -$186.5M | -809.5% | -836.4% |
| Pre-tax Income | -$257.8M | -485.6% | -5775.5% |
| Income Tax | $1K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $878K | -78.6% | +1040.3% |
| Accounts Receivable | $11.9M | -28.8% | -62.2% |
| Inventory | $1.1M | -57.0% | -55.0% |
| Current Assets | $16.5M | -51.0% | -58.6% |
| Total Assets | $275.9M | +229.4% | +174.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $21.3M | — | — |
| Investing Cash Flow | -$700K | — | — |
| Financing Cash Flow | -$23.0M | — | — |
| -94.7% |
| — |
| Net Income | -$257.8M | -485.3% | -5775.6% |
| EPS (Basic) | -$22.17 | -198.8% | — |
| EPS (Diluted) | -$22.17 | -198.8% | — |
| $358.9M |
| +17.3% |
| +27.5% |
| Total Liabilities | $455.6M | +36.9% | +46.1% |
| Stockholders' Equity | -$176.9M | +28.9% | +16.3% |